NEW
Stock Screener with Intrinsic Value
Summit Therapeutics Inc. (SMMT)
Last Price$19.04.6%
Market Cap$13.8B
(2,476.8%)
Industry median - (122.4%)
5Y Historical average - (1,269.4%)
(2,483.9%)
Industry median - (129.8%)
5Y Historical average - (1,275.1%)
(62.1%)
Industry median - (52.2%)
5Y Historical average - (185.3%)
(58.0%)
Industry median - (51.2%)
5Y Historical average - (113.5%)
SMMT Capital Allocation Rating
Crunching data... Almost there!
SMMT Capital Allocation metrics
Crunching data... Almost there!
Competing with SMMT Capital Allocation
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Summit Therapeutics Inc. (SMMT) ROIC (Return on Invested Capital)?
The Summit Therapeutics Inc. (SMMT) ROIC is (2,476.8%), compared to the industry median of ((122.4%)) and the 5-year historical average of (1,269.4%).
What is the Summit Therapeutics Inc. (SMMT) ROIC minus WACC (Weighted Average Cost of Capital)?
The Summit Therapeutics Inc. (SMMT) ROIC minus WACC is (2,483.9%), compared to the industry median of ((129.8%)) and the 5-year historical average of (1,275.1%).
What is the Summit Therapeutics Inc. (SMMT) ROE (Return on Equity)?
The Summit Therapeutics Inc. (SMMT) ROE is (62.1%), compared to the industry median of ((52.2%)) and the 5-year historical average of (185.3%).
What is the Summit Therapeutics Inc. (SMMT) ROCE (Return on Capital Employed)?
The Summit Therapeutics Inc. (SMMT) ROCE is (58.0%), compared to the industry median of ((51.2%)) and the 5-year historical average of (113.5%).